RA Medical Systems Performance
| RMEDDelisted Stock | USD 0.68 0.02 2.86% |
The firm owns a Beta (Systematic Risk) of 0.79, which implies possible diversification benefits within a given portfolio. As returns on the market increase, RA Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding RA Medical is expected to be smaller as well. RA Medical Systems today owns a risk of 0.0%. Please check RA Medical Systems coefficient of variation, value at risk, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if RA Medical Systems will be following its current price history.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days RA Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, RA Medical is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 15 M |
RMED |
RA Medical Relative Risk vs. Return Landscape
If you would invest 68.00 in RA Medical Systems on August 31, 2024 and sell it today you would earn a total of 0.00 from holding RA Medical Systems or generate 0.0% return on investment over 90 days. RA Medical Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than RMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
RA Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RA Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RA Medical Systems, and traders can use it to determine the average amount a RA Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RMED |
Based on monthly moving average RA Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RA Medical by adding RA Medical to a well-diversified portfolio.
RA Medical Fundamentals Growth
RMED Stock prices reflect investors' perceptions of the future prospects and financial health of RA Medical, and RA Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RMED Stock performance.
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (307.60) % | |||
| Current Valuation | (8.89 M) | |||
| Shares Outstanding | 6.46 M | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 604.06 X | |||
| Revenue | 14 K | |||
| EBITDA | (18.2 M) | |||
| Cash And Equivalents | 13.66 M | |||
| Cash Per Share | 9.60 X | |||
| Total Debt | 124.17 K | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 6.81 X | |||
| Cash Flow From Operations | (22.57 M) | |||
| Earnings Per Share | (35.78) X | |||
| Total Asset | 16.84 M | |||
| Retained Earnings | (205.14 M) | |||
About RA Medical Performance
By analyzing RA Medical's fundamental ratios, stakeholders can gain valuable insights into RA Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if RA Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if RA Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. Ra Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 58 people.Things to note about RA Medical Systems performance evaluation
Checking the ongoing alerts about RA Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RA Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RA Medical Systems is not yet fully synchronised with the market data | |
| RA Medical Systems has some characteristics of a very speculative penny stock | |
| RA Medical Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 14 K. Net Loss for the year was (26.86 M) with loss before overhead, payroll, taxes, and interest of (1.54 M). | |
| RA Medical Systems currently holds about 13.66 M in cash with (22.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 37.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing RA Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RA Medical's stock is overvalued or undervalued compared to its peers.
- Examining RA Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RA Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RA Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RA Medical's stock. These opinions can provide insight into RA Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |